Iniciar sesión
Registrarse
Restablecer contraseña
Publicar y Distribuir
Soluciones de Publicación
Soluciones de Distribución
Temas
Publicaciones
Revistas
Libros
Actas
Editoriales
Blog
Contacto
Buscar
Carrito
EUR
USD
GBP
Español
English
Deutsch
Polski
Español
Français
Italiano
Home
Revistas
The EuroBiotech Journal
Volumen 3 (2019): Edición 2 (April 2019)
Acceso abierto
Future Biotechnology
Munis Dundar
Munis Dundar
,
Satya Prakash
Satya Prakash
,
Ratnesh Lal
Ratnesh Lal
y
Donald K. Martin
Donald K. Martin
| 24 abr 2019
The EuroBiotech Journal
Volumen 3 (2019): Edición 2 (April 2019)
Acerca de este artículo
Artículo anterior
Artículo siguiente
Resumen
Artículo
Figuras y tablas
Referencias
Autores
Artículos en este número
Vista previa
PDF
Cite
Compartir
Article Category:
Review
Publicado en línea:
24 abr 2019
Páginas:
53 - 56
DOI:
https://doi.org/10.2478/ebtj-2019-0006
Palabras clave
Medical biotechnology
,
nanotechnology
,
genetics
,
future developments
© 2019 Munis Dundar, Satya Prakash, Ratnesh Lal, Donald K. Martin, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.
Figure 1
Overview of the human genome. Gene and gene-related sequences cover 37.5% of the human genome, while genome-wide repeats constitute 43.75%. The remaining 18.75% are intergenic regions.
Figure 2
Examples of symbio-bots (A–D) that can be created in a bioinspired way (E). Each device is separated with a smart porous packaging that allows a duplex communication. Therapeutic cells (A and B) need a porous encapsulation that avoids an immune reaction and allows protection from both sides. They may be human cells, as MSC or specialized cells such as β-cell from Langherans islets (A), or other eukaryotic or prokaryotic cells (B). Panel C shows an IBFC linked to an electronic medical device. Panel D shows a generic device delivering a therapeutic molecule. Panel E: Existing symbiosis (i.e., microbiota or pregnancy) are a source of bio-inspiration to establish a duplex communication between the body and its implants. Regenerative medicine should embrace this concept of bioinspiration for a better design and integration of implants, especially for future symbio-bots. (reproduced with permission from Alcaraz et al (10)).